Cancer Profiling Market
Cancer Profiling Market Size, Share and Industry Analysis Report By Technology (Immunoassay, NGS, PCR, Mass Spectrometry, In-Situ Hybridization and Microarrays); By Cancer Type (Breast, Lung, Colorectal, Prostate Cancer and Melanoma Cancer); By Biomarker Type (Genomic Biomarkers and Protein Biomarkers); By Application (Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Treatment and Monitoring) - Forecast Year 2024 – 2031
Healthcare // Diagnostic Imaging
Cancer Profiling Market Analysis and Precision Oncology
Trends
The Cancer Profiling Market is undergoing a revolution in
the field of oncology, driving the shift toward personalized and targeted
cancer treatments. Cancer profiling, which involves the analysis of a patient's
genetic, molecular, and clinical information, has transformed the way cancer is
diagnosed, treated, and managed. This report provides an in-depth analysis of
the current state of the Cancer Profiling Market, its key drivers, challenges,
and the emerging trends that will shape its future.
Cancer profiling involves the comprehensive examination of a
patient's cancer cells and genetic makeup to gain insights into the disease's
characteristics, enabling tailored treatment strategies.
Market Overview:
The Cancer Profiling Market has witnessed significant growth
due to several key factors:
- Precision Oncology:
Advances in genomics, proteomics, and bioinformatics have enabled the
development of personalized cancer treatment strategies, improving patient
outcomes.
- Biomarker Discovery:
Cancer profiling assists in the discovery of specific biomarkers, aiding in
early cancer detection, prognosis assessment, and treatment response
prediction.
- Targeted Therapies:
The identification of genetic mutations and molecular alterations has led to
the development of targeted therapies that selectively attack cancer cells
while sparing healthy tissue.
- Immuno-Oncology:
Cancer profiling plays a crucial role in immuno-oncology, guiding the
development of immunotherapies that harness the body's immune system to fight
cancer.
Market Segmentation:
The Cancer Profiling Market can be segmented based on
various criteria:
Technology:
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Mass Spectrometry
- In Situ Hybridization (ISH)
Others
Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Leukemia
- Others
End-User:
- Hospitals and Clinics
- Research Institutes and Academic Centers
- Pharmaceutical and Biotechnology Companies
Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Challenges and Opportunities:
The Cancer Profiling Market faces challenges related to data
privacy, cost, and accessibility to advanced technologies. However, these
challenges present opportunities for innovation in data security, cost-effective
profiling solutions, and broader adoption of precision oncology.
Competitive
Landscape:
Key players in the Cancer Profiling Market include companies
such as Illumina, Inc., Thermo Fisher Scientific, and QIAGEN N.V. Competition
centers on technology advancements, test accuracy, and collaborations with
healthcare providers.
Dominating Companies in Cancer Profiling Market
- ILLUMINA, INC.
- QIAGEN N.V.
- NEOGENOMICS, INC.
- SYSMEX CORPORATION
- HTG MOLECULAR DIAGNOSTICS, INC.
- PREDICTIVE ONCOLOGY, INC. (HELOMICS CORPORATION)
- CARIS LIFE SCIENCES
- NANOSTRING TECHNOLOGIES, INC.
- GUARDANT HEALTH, INC.
- FOUNDATION MEDICINE, INC.
- F. HOFFMANN-LA ROCHE LTD
- THERMO FISHER SCIENTIFIC INC.
- GENSCRIPT BIOTECH CORPORATION
- TEMPUS LABS
- HOLOGIC, INC.
- EXACT SCIENCES
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- PERSONALIS, INC.
- BOREAL GENOMICS INC.
- STRAND LIFE SCIENCES
- LUCENCE HEALTH, INC.
- ACT GENOMICS CO., LTD.
- IMB DX, INC.
- PERTHERA
- AGENDIA
Future Outlook:
The Cancer Profiling Market is poised for continued growth
as precision oncology becomes a standard approach in cancer care. Advances in
genomics, AI-driven analysis, and liquid biopsy techniques are expected to
drive market expansion.
The Cancer Profiling Market is a pivotal enabler of
precision medicine in oncology, transforming cancer diagnosis and treatment.
This report provides valuable insights into the market's current state,
challenges, and future prospects, serving as a resource for decision-makers,
healthcare professionals, and researchers in the field of oncology.
For comprehensive market analysis, including market size, growth projections, and competitive analysis, please refer to the complete report.
Cancer Profiling Market - Get your Free sample copy of the Report
:::::::::::::::>
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States